Filing metadata

Accession number
0001567619-23-001474
Form type
Form 4
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Jan 30, 2023
Reporting period
Jan 26, 2023
Description
Insider transaction

Explore SEC Filings Hub